REFERENCES
- Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163–191.
- Okhravi N, Odufuwa B, McCluskey P, et al. Scleritis. Surv Ophthalmol. 2005;50:351–363.
- Lachmann SM, Hazleman BL, Watson PG. Scleritis and associated disease. Br Med J. 1978;1:88–90.
- Wieringa WG, Wieringa JE, ten Dam-van Loon NH, et al. Visual outcome, treatment results, and prognostic factors in patients with scleritis. Ophthalmology. 2013;120:379–386.
- Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119:43–50.
- Lyne AJ, Pitkeathley DA. Episcleritis and scleritis. Association with connective tissue disease. Arch Ophthalmol. 1968;80:171–176.
- Ho YF, Yeh LK, Tan HY, et al. Infectious scleritis in Taiwan-a 10-year review in a tertiary-care hospital. Cornea. 2014;33:838–843.
- Smith JR, Mackensen F, Rosenbaum JT. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol. 2007;3:219–226.
- Keino H, Watanabe T, Taki W, et al. Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol. 2010;94:1459–1463.
- Erkanli L, Akova YA, Guney-Tefekli E, et al. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey. Cornea. 2010;29:26–33.
- Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389–396.
- Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467–471.
- Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469–476.
- McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106:2380–2386.
- Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, et al. Scleritis therapy. Ophthalmology. 2012;119:51–58.
- Beardsley RM, Suhler EB, Rosenbaum JT, et al. Pharmacotherapy of scleritis: current paradigms and future directions. Expert Opin Pharmacother. 2013;14:411–424.
- McCluskey P, Wakefield D. Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol. 1987;105:793–797.